22nd Century is a plant biotechnology company focused on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. The company’s smoking cessation products and modified risk tobacco products are aimed at smokers who find it difficult to quit and therefore may be interested in cigarettes which reduce exposure to certain tobacco smoke toxins that offer lower health risks than regular cigarettes.  For more information, visit the company’s website at www.xxiicentury.com